abstracts

0

Page précédente

Abstracts Strasbourg 2004

Type présentation Jour(s) N° Session Auteurs Titre Adresses
Poster 26-28   27  P128 K Marechal (1); H Bagheri (1); F Taboulet (2); JL Montastruc (1); Adverse drug reactions and off-label drug use: a study of cases registered by the Midi-Pyrénées Pharmacovigilance Centre between 1997 and 2000 
Abstract complet
(1) Service de Pharmacologie Clinique, CRPV, EA 3696, Faculté de médecine, Toulouse; (2) Droit Pharmaceutique et Economie de la Santé, Faculté de Pharmacie, Toulouse;
Poster 26-28   27  P129 M Villiet (1); V Alibert (1); V Pinzani (1); H Peyrière (1); H Breton (1); D Hillaire-Buys (1); JP Blayac (1); Side effects, related to oxcarbazepine therapy. Analysis of cases reported in French Pharmacovigilance Database 
Abstract complet
(1) Pharmacologie Médicale et Toxicologie, CHU Lapeyronie, Montpellier;
Poster 26-28   27  P130 AS Lemaire-Hurtel (1); V Gras (1); L Hary (1); E Lorne (2); H Masson (1); B De Cagny (2); M Andrejak (1); Piperacilline/tazobactam induced seizures 
Abstract complet
(1) Service de Pharmacologie, CHU Amiens, Amiens; (2) Service de Réanimation Néphrologique, CHU Amiens, Amiens;
Poster 26-28   27  P131 V Gras-Champel (1); A Munier (1); H Masson (1); N Bernard (2); MJ Jean-Pastor (3); S Gautier (4); AS Lemaire-Hurtel (1); M Andréjak (1); Z Massy (1); Zoledronate-associated acute renal failure : a propos of four cases 
Abstract complet
(1) Pharmacovigilance Regional Center, CHU Amiens, Amiens; (2) Pharmacovigilance Regional Center, CHU Lyon, Lyon; (3) Pharmacovigilance Regional Center, CHU Marseille, Marseille; (4) Pharmacovigilance Regional Center, CHU Lille, Lille;
Poster 26-28   27  P132 MJ Jean-Pastor (1); M Ostorero-Brun (2); A Pakleza (1); M Boyer (1); B Gueniot (1); F Rodor (1); Hypertension following inhaled beclomethasone 
Abstract complet
(1) Centre Régional de Pharmacovigilance, Hôpital Salvator AP-HM, Marseille; (2) Médecin Allergologue, Hermès Park, avenue d’Haifa, Marseille;
Poster 26-28   27  P133 F Rodor (1); M Boyer (1); B Gueniot (1); A Pakleza (1); N Prost (1); MJ Jean-Pastor (1); Carbamazepine and hypercholesterolemia 
Abstract complet
(1) Centre Régional de Pharmacovigilance, Hôpital Salvator AP-HM, Marseille;
Poster 26-28   27  P134 F Rodor (1); M Boyer (1); A Pakleza (1); B Gueniot (1); MJ Jean-Pastor (1); Are fibric derivatives concerned with tendinitis 
Abstract complet
(1) Centre Régional de Pharmacovigilance, Hôpital Salvator AP-HM, Marseille;
Poster 26-28   27  P135 MJ Jean-Pastor (1); C Lavagne (2); F Rodor (1); Y Frances (2); Adverse events in hospitalised patients : a prospective study 
Abstract complet
(1) Centre Régional de Pharmacovigilance, Hôpital Salvator AP-HM, Marseille; (2) Service de Médecine Interne et Gériatrie, Hôpital Nord AP-HM, Marseille;
Poster 26-28   27  P136 K Masmoudi (1); V Gras-Champel (1); AS Lemaire-Hurtel (1); JM Geslin (1); H Masson (1); A Munier (1); G Decoq (1); M Andréjak (1); Extrapyramidal side-effects of veralipride, a drug used to treat menopausal hot flushes : a propos of 17 cases 
Abstract complet
(1) Service de Pharmacologie Clinique, CHU Amiens, Amiens;
Poster 26-28   27  P137 A Pathak (1); P Debats (1); JL Montatstruc (1); JM Senard (1); Intestinal Obstruction associated with oral midodrine: first case report 
Abstract complet
(1) Service de Pharmacologie Clinique, CRPV, Toulouse;
Poster 26-28   27  P138 A Pathak (1); JM Senard (1); H Bagheri (1); M Lapeyre (1); JL Montastruc (1); Medication Error caused by confusion in drug blister: first case report 
Abstract complet
(1) Service de Pharmacologie, CRPV, Toulouse;
Poster 26-28   27  P139 B Baldin (1); G Pattyn (2); JL Baldin (3); RM Chichmanian (1); The study of incidence and management of adverse drug reactions in general medical practice 
Abstract complet
(1) Centre Régional de Pharmacovigilance, Hôpital Pasteur, 30 avenue de la voie romaine, Nice; (2) 563 avenue edouard Baudoin, Medecin generaliste, Levens; (3) Route de l’Aire Saint Michel, Medecin generaliste, Falicon;
Poster 26-28   27  P140 I Cardiet (1); S Foucault (1); E Polard (1); F Colin (1); H Allain (2); NSAIDs and contra-indication in pregnancy: what about this information in pharmacists 
Abstract complet
(1) CRPV, Hopital Pontchaillou, Rennes ; (2) CRPV, Pontchaillou, Rennes;
Poster 26-28   27  P141 C Vigneau (1); G Veyrac (2); M Guerlais (2); P Jolliet (2); Evaluation of drug addiction using the National Pharmacovigilance database 
Abstract complet
(1) Centre d’Evaluation et d’Information sur les Pharmacodépendances, Institut de Biologie, 9 quai Moncousu, Nantes; (2) Centre Régional de Pharmacovigilance, Institut de Biologie, 9 quai Moncousu, Nantes;
Poster 26-28   27  P142 G Veyrac (1); C Guitton (2); A Chiffoleau (1); P Jolliet (1); Unexpected aggravation of myasthenia by telithromycin : the two first cases of respiratory distress 
Abstract complet
(1) Centre Régional de Pharmacovigilance, Institut de Biologie, 9 quai Moncousu, Nantes; (2) Service de Réanimation Médicale Polyvalente, Immeuble Jean Monnet – CHU, Nantes;
Poster 26-28   27  P143 P Lochet (1); N Mirfendereski (1); S Louvety (2); D Hillaire-Buys (1); H Peyrière (1); V Pinzani (1); JP Blayac (1); Acute pancreatitis induced by pristinamycin : case report with positive rechallenge 
Abstract complet
(1) Service de Pharmacovigilance, Hopital Lapeyronie, Montpellier; (2) Service de Maladie du Foie et de l’Appareil Digestif, Centre Médical 158, Montpellier;
Poster 26-28   27  P144 G Veyrac (1); C Vigneau (2); D Bourneau (1); P Jolliet (1); Study of adverse drug reactions reported during 6 months by pharmacy students 
Abstract complet
(1) Centre Régional de Pharmacovigilance, Institut de Biologie, 9 quai Moncousu, Nantes; (2) Centre d’Evaluation et d’Information sur les Pharmacodépendances, Institut de Biologie, 9 quai Moncousu, Nantes;
Poster 26-28   27  P145 C Louvigné (1); G Veyrac (1); A Chiffoleau (1); E Chailleux (2); P Jolliet (1); Thromboembolic events with anastrozole 
Abstract complet
(1) Centre Régional de Pharmacovigilance, Institut de Biologie, 9 quai Moncousu, Nantes; (2) Service de Pneumologie, Hôpital G. et R. Laënnec, Nantes;
Poster 26-28   27  P146 A Chiffoleau (1); G Le Grand (2); C Vigneau (1); F Doisy (2); M Sambe (2); P Jolliet (1); Contra-indicated drugs’s exposure in pregnancies identified in a regional French Health Insurance system : a two-year retrospective analysis 
Abstract complet
(1) Centre Régional de Pharmacovigilance, Institut de Biologie, 9 quai Moncousu, Nantes; (2) Direction Gérérale du Service Médical des Pays de Loire (CNAMTS), 9 rue du Président Edouard Herriot, Nantes;
Poster 26-28   27  P147 A Chiffoleau (1); M Bourgeois (1); G Veyrac (1); O Billon (2); N Winer (3); D Duveau (4); P Despins (4); P Jolliet (1); Pregnancies in women treated with oral anticoagulants : case reports and review in 2002-2003 
Abstract complet
(1) Centre Régional de Pharmacovigilance, Institut de Biologie, 9 quai Moncousu, Nantes; (2) Service d’Obstétrique et Médecine Foetale, Hôpital de la Mère et l’Enfant, Nantes; (3) Service de Clinique Cardiologique et des Maladies Vasculaires, Hôpital G. et R. Laënnec, Nantes; (4) Service de Chirurgie Thoracique et Cardiovasculaire, Hôpital G. et R. Laënnec, Nantes;

Page précédente